KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Intangibles (2016 - 2026)

Bristol Myers Squibb has reported Intangibles over the past 18 years, most recently at $18.2 billion for Q1 2026.

  • Quarterly Intangibles fell 18.87% to $18.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $18.2 billion through Mar 2026, down 18.87% year-over-year, with the annual reading at $19.1 billion for FY2025, 18.04% down from the prior year.
  • Intangibles was $18.2 billion for Q1 2026 at Bristol Myers Squibb, down from $19.1 billion in the prior quarter.
  • Over five years, Intangibles peaked at $40.1 billion in Q1 2022 and troughed at $18.2 billion in Q1 2026.
  • The 5-year median for Intangibles is $29.0 billion (2023), against an average of $28.6 billion.
  • Year-over-year, Intangibles dropped 2.41% in 2024 and then plummeted 31.36% in 2025.
  • A 5-year view of Intangibles shows it stood at $35.9 billion in 2022, then dropped by 24.5% to $27.1 billion in 2023, then dropped by 13.91% to $23.3 billion in 2024, then dropped by 18.04% to $19.1 billion in 2025, then decreased by 4.5% to $18.2 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Intangibles are $18.2 billion (Q1 2026), $19.1 billion (Q4 2025), and $20.5 billion (Q3 2025).